From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

Experts And Viewpoints, October 02, 2006 An Expert Interview With Dr. Cal Cohen Recent approvals of new HIV drugs and a rich ... comparison of commercial phenotypic tests, and more.

Xmoor pharma, the full-service cell and gene therapy (CGT) manufacturing partner, and Virica Biotech Inc. ("Virica"), a leading developer of enhancers for scaling of viral vectors as well as cell and ...

frequently within the context of commercial sex work (Shankle 2006). Needle injection practices may also increase risk for HIV through unsafe injection of recreational drugs or substances to alter ...

The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...

The Biden administration on Monday proposed making over-the-counter contraception available at no cost and with fewer ...

Rwanda is making its third bid of investing in pharma, seeking to put pension funds in an industry with great potential but ...

With the rise of interest in true crime in recent years, films and TV shows that depict shocking crimes and complicated ...

From having the most dog-friendly cities to dealing with the highest obesity rates, here are the best—and worst—qualities of ...

The Biden-Harris administration has a historic opportunity to help end HIV. New, cutting-edge drugs that prevent HIV are ...

In the last 30 years, HIV rates have gone down, in large part because of the game-changing prescription drug pre-exposure ...

It is a combination of oral PrEP for HIV prevention and oral contraception. As both drugs are approved, the new combination has to be proven to show its efficacy. The pill, made by Viatris ...